Close Menu

NEW YORK (GenomeWeb) – Quebec City-based GenePOC announced today that it has obtained clearance from the US Food and Drug Administration for a small molecular diagnostic panel test to detect carbapenem drug resistance.

The test is the fourth assay on the GenePOC Revogene system, and it detects five gene sequences in carbapenem-producing organisms (CPOs) that are most commonly associated with resistance.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.